← Leaderboards
Cheryl Claunch-Rabe
Oregon Health & Science University
$182,234
Attributed
$182,234
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$182,234 · 1
By mechanism
F30$182,234 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jeffrey Wallace Tyner$13,872,769
- Lisa J Wood$3,498,714
- Anupriya Agarwal$8,829,719
- Savannah Corrina Partridge$6,244,824
- Nathalie R Javidi-Sharifi$144,372
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseBayesian AnalysisBaseCancer CellCancer Cell LineCancer PatientCancer RecurrenceBladder Transitional Cell CarcinomaCellsCellular StressCessation Of LifeChemotherapyCytokineDiagnosisDifferential ExpressionEventExhibitsCell DeathExtracellular MatrixFgfr3 GeneFoundationsGenesGrowthGrowth Factor
Grant awards (4)
Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition$33,650
F30 · FY2020 · CA · contact PI
Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition$50,016
F30 · FY2019 · CA · contact PI
Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition$49,524
F30 · FY2018 · CA · contact PI
Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition$49,044
F30 · FY2017 · CA · contact PI